Skip to main content
. 2010 Jan 20;115(12):2508–2519. doi: 10.1182/blood-2009-06-225631

Table 2.

Modifying factors of the longitudinal trends of QOL domains for autologous transplantation (HCT) patients

Modifying factor* Percent change (effect size) in QOL domain score by modifying factor
QOL domain
Physical
Psychological
Social
Spiritual
Pre-HCT Post-HCT Pre-HCT Post-HCT Pre-HCT Post-HCT Pre-HCT Post-HCT
Age at referent HCT, per year increase −0.21%** (0.01) 0.63%†† (0.02) 0.79%†† (0.03) 0.47%‡‡ (0.02)
Race/ethnicity
    African American, Hispanic (vs white, Asian, other) −4.0%** (0.18)
    Asian, other (vs white, Hispanics, African American) 15.4%‡‡ (0.70)
Married§ (vs single, divorced/widowed/separated) 9.9%** (0.34)
Annual household income less than $75 000 (vs $75 000 or more) −10.1%‡‡ (0.45) −8.4%** (0.29)
Education
    Less than or more than high school (vs high school only) −22.4%†† (0.69) −11.2%** (0.40) −14.0%** (0.49) −11.8%** (0.41)
    Bachelor degree or higher (vs less than Bachelor degree) −12.1%‡‡ (0.47) −11.9%‡‡ (0.58)
BMI§ in kg/m2, per unit increase −0.16%‡‡ (0.01)
Change in BMI from pre-HCT level,§, per unit decrease NA NA −0.73%‡‡ (0.03) NA NA
Primary diagnosis
    Group,# 2,4,5,7 (vs group 3) −20.8%†† (−1.27)
    Groups 2,3 (vs groups 4,5,7) −9.5%** (0.42)
High risk of relapse at HCT (vs low risk) −8.1%** (0.28)
One transplant (vs more than 1 transplant) −16.4%‡‡ (0.52) 8.3%** (0.39)

— indicates statistically non-significant factors (P > .05); therefore percent change and ES are not shown. NA indicates not applicable.

*

Referent groups are shown in parentheses. Other factors examined that were nonsignificant in the multivariate GEE regression include: sex, disease relapse status, pre-HCT exposure to total body irradiation and chemotherapy-based conditioning agents.

Percent change is calculated as [(expected level of the index group − expected level of the referent group)/(expected level of the referent group)] × 100. For age and BMI, expected levels corresponding to their means at pre-HCT were used as referent levels. For post-HCT, the average of the 4 time points is reported. Positive percent change indicates more favorable QOL in the index group.

Effect size at a particular time point is computed as the absolute value of (expected level of the index group − expected level of the referent group)/observed common SD at that time point. At post-HCT, the average effect size of the 4 time points is reported.

§

Time-varying: values concurrent to QOL scores were used.

BMI at follow-up minus BMI at pre-HCT.

Group 1: ALL; Group 2: AML, APL; Group 3: Amyloidosis, CLL, Hypereosinophilic syndrome, other-Amyl, POEMS, renal cancer, SAA, CML; Group 4: HD'; Group 5: LBL, NHL, Other-lymph; Group 6: MDS, MPD, myelofibrosis, other-MPP; Group 7: MM.

#

Disease groups 1 and 6 did not occur under autologous HCT.

**

Value of P < .05.

††

Value of P < .001.

‡‡

Value of P < .01.

HHS Vulnerability Disclosure